October 29, 2021
A Delaware federal judge has granted Takeda Pharmaceutical's request for injunctions against two generic-drug makers in its legal war to protect its grip on the antidepressants Brintellix and Trintellix, but rejected its last-ditch effort to hit Lupin Pharmaceuticals with an injunction too.